Can Pudu Robotics crack Asia’s SME automation market with its new T150 robot?
Pudu Robotics debuts the T150 robot for light-payload industrial delivery. Find out how it could transform small factory automation in Asia. Read More
GSK wins approval in China for Nucala in eosinophilic COPD, expanding respiratory biologics reach
Find out how GSK’s Nucala just became the first biologic approved for eosinophilic COPD in China—and what it means for the future of respiratory care. Read More
US captures Venezuelan President Nicolás Maduro in military operation; legal and geopolitical fallout begins
The United States has captured Venezuelan President Nicolás Maduro in a military operation. Find out how this action is reshaping global and regional politics. Read More
Can JIADE’s Chinalink pact become a new blueprint for China–South Korea academic ties?
JIADE teams up with Chinalink Education South Korea to launch joint academic programs. Explore how this could reshape Asia’s cross-border education market. Read More
Why Nasdaq flagged WF International (Nasdaq: WFIH)—and what happens if it doesn’t fix its stock price
WF International has six months to fix its share price or risk delisting from Nasdaq. Explore what’s next in its battle to regain compliance. Read More
HiTHIUM’s 8-hour battery system claims 97% efficiency—can it beat iron-air rivals?
HiTHIUM’s 8-hour-native lithium battery system could redefine long-duration energy storage economics. Find out how the new design might shift global energy baselines. Read More
SK Chemicals bets on feedstock certainty with Korea’s first vertical recycling chain
SK Chemicals’ joint venture with Kelinle brings Korea its first vertically integrated recycling value chain. Find out how this could change the plastics industry. Read More
Leqembi gains traction in China as commercial insurance innovative drug list expands access for Alzheimer’s patients
Leqembi gains commercial insurance status in China, opening doors for Alzheimer’s patients and transforming access. Find out what this means for BioArctic AB and Eisai. Read More
CARsgen showcases early clinical results for CT0596 allogeneic BCMA CAR-T cell therapy in multiple myeloma
CARsgen unveils early CT0596 CAR-T trial results at ASH 2025, showing deep responses and strong tolerability in multiple myeloma. See what’s next for the therapy. Read More
India becomes Asia’s newest major power: What the 2025 Asia Power Index really tells us about regional influence
Find out how India’s new major power status in the 2025 Asia Power Index reshapes Asia’s strategic balance and what it means for regional geopolitics ... Read More